ejection-fraction

Documents about ejection-fraction

• Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427#826130ClinicalTrials.gov
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)#874620ClinicalTrials.gov
• Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial#880993ClinicalTrials.gov
• Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure#851950ClinicalTrials.gov
• A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction#909648ClinicalTrials.gov
• Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction#910394ClinicalTrials.gov
• The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction#180329ClinicalTrials.gov
• The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%#805590ClinicalTrials.gov
• Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure#843762ClinicalTrials.gov
• Thoracic Epidural Anesthesia Reduces Mortality and Rehospitalization for Patients With Heart Failure With Reduced Ejection Fraction#981444ClinicalTrials.gov
• Exercise Lower-body Negative Pressure in Heart Failure With Preserved Ejection Fraction#833121ClinicalTrials.gov
• NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)#840816ClinicalTrials.gov
• BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction#845874ClinicalTrials.gov
• Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial#121518ClinicalTrials.gov
• An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting#838169ClinicalTrials.gov
• Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy#868707ClinicalTrials.gov
• CAPTURE-HFpEF: National Study of Identification and Phenotyping of Heart Failure With Preserved Ejection Fraction#883681ClinicalTrials.gov
• Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)#901842ClinicalTrials.gov
• Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.#848349ClinicalTrials.gov
• Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction#366666ClinicalTrials.gov
• TRANSFORM Heart Failure with Reduced Ejection Fraction#863424ClinicalTrials.gov
• Evaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Learning-based Image Reconstructions#201671ClinicalTrials.gov
• Yôga and Breathing Techniques Training in Patients With Heart Failure and Preserved Ejection Fraction#978948ClinicalTrials.gov
• Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats#330364HAL (France)
• Beyond Ejection Fraction: Screening and Anaesthetic Management of Cancer Therapy- Related Cardiac dysfunction (CTRCD)#384355Figshare
• EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction#803958ClinicalTrials.gov
• Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction#825826ClinicalTrials.gov
• Effects of a Multidisciplinary Integrated Care Model on Care Outcomes in Patients With Heart Failure With Preserved Ejection Fraction#834718ClinicalTrials.gov
• Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients#897968ClinicalTrials.gov
• Echocardiogram and Cardiac Performance System (CPS) Ejection Fraction Validation Study#804103ClinicalTrials.gov
• Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension#383641ClinicalTrials.gov
• Boston Medical Center Ultrasound Decongestion Study in Heart Failure#826843ClinicalTrials.gov
• Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study#850025ClinicalTrials.gov
• Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial#126834HAL (France)
• Development of Specific Diagnostic Tools for Cardiac Insufficiency With Preserved Ejection Fraction#175016ClinicalTrials.gov
• Learning Curve CUSUM of LV Ejection Fraction by Visual Estimation in Novice Practitioners#843115ClinicalTrials.gov
• External Body Pressure in Heart Failure With Preserved Ejection Fraction#994999ClinicalTrials.gov
• Comparison Between Endogenous and Exogenous Ketosis in Patients With Non-ischemic Chronic Heart Failure With Reduced Ejection Fraction#882958ClinicalTrials.gov
• randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure#910819ClinicalTrials.gov
• Exercise training improves cardiac autonomic control, cardiac function, and arrhythmogenesis in rats with preserved-ejection fraction heart failure#948056Repositorio de Universidad Autónoma de Chile.
• Testing the CHAT Program for Patients With Heart Failure#980741ClinicalTrials.gov
• A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]#800291ClinicalTrials.gov
• Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)#860621ClinicalTrials.gov
• Unsaturated Fatty Acids Enriched-diet to Improve Cardiorespiratory Fitness, Metabolic Flexibility and Glucose Tolerance in Obese Patients#896538ClinicalTrials.gov
• Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF)#67711ClinicalTrials.gov
• Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation#417468ClinicalTrials.gov
• Matching Perfusion and Metabolic Activity in HFpEF#830102ClinicalTrials.gov
• Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment#869142ClinicalTrials.gov
• Pacing for Heart Failure With Preserved Ejection Fraction#901965ClinicalTrials.gov
• Viral respiratory tract infections in heart failure: the FINEARTS-HF trial#202612HAL (France)